00

Shenzhen Salubris Pharmaceuticals Co LtdSHE 002294 Stock Report

Last reporting period 30 Jun, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

4.839

Middle

Exchange

XSHE - Shenzhen Stock Exchange

002294.SZ Stock Analysis

00

Uncovered

Shenzhen Salubris Pharmaceuticals Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

77/100

Moderate score

Market cap $B

4.839

Dividend yield

1.79 %

Shares outstanding

1 091.36 B

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 3,236 full-time employees. The company went IPO on 2009-09-10. The firm provides two categories of products: pharmaceutical preparation and bulk drugs. The firm is also engaged in the research and development, production and sales of cardiovascular medical devices. The firm distributes its products within domestic market and to overseas markets.

View Section: Eyestock Rating